BioSpace News Archive

Business

Visioneering Launches NaturalVue® Brand Contact Lenses for Myopia Progression Control & Presbyopia in the United Kingdom

US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘The Company’) has announced its launch into the UK.

February 22, 2019

·

1 min read

Drug Development

AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006

AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer’s disease and Progressive Supranuclear Palsy (PSP), announced today the successful completion of the latest phase 1 study regarding the effect of food intake for its drug candidate AZP2006.

February 22, 2019

·

3 min read

Business

WellCare Announces Appearances At Investor Conferences

WellCare Health Plans, Inc. announced that members of its management team are scheduled to present at two upcoming conferences in March 2019.

February 22, 2019

·

1 min read

Business

Daiichi Sankyo Shifts Several Top Leaders to New Roles for Company’s Launch into its Next Growth Phase

Dr. Junichi Koga to become new global Head of Research & Development Unit and Co-Chair of the company’s Global Executive Meeting of R&D (GEMRAD), the top decision-making body in R&D

February 22, 2019

·

4 min read

Business

AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies

AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Voyager Therapeutics, Inc. (Nasdaq: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced an exclusive, global strategic collaboration

February 22, 2019

·

8 min read

Deals

REPEAT/Halo Labs Commences Trading on the OTCQB Venture Market in the United States under the Symbol AGEEF

Halo Labs Inc. is pleased to announce that OTC Markets Group Inc.

February 22, 2019

·

6 min read

Deals

Ignite International Brands Terminates Letter of Intent to Acquire Gen X Biosciences Corp.

Ignite International Brands, Ltd. announces that, as a result of its due diligence, it has terminated its letter of intent to acquire all of the issued and outstanding common shares in Gen X BioSciences Corp.

February 22, 2019

·

2 min read

Policy

Indian High Court in Chennai Delivers a Decisive Product Patent Victory to Kibow Biotech Inc Specializing in Kidney Health Supplement “Renadyl™" - the Flagship Product for its “Enteric Dialysis®" Platform Technology

Kibow Biotech Inc is pleased to announce that it has achieved a significant victory with its India patent in a lawsuit brought by La Renon an Ahmedabad based company. [Patent No. 351/MUMNP/2006, 224100 “Compositions for Augmenting Kidney Function” Patent No. 224100, - issued September 29, 2008].

February 22, 2019

·

5 min read

Business

Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress

Heron Therapeutics, Inc. reported financial results for the three and twelve months ended December 31, 2018 and highlighted recent corporate progress.

February 22, 2019

·

9 min read

FDA

Imbrium Therapeutics Announces U.S. FDA Orphan Drug Designation for Etoposide Toniribate for the Treatment of Relapsed Refractory Biliary Tract Cancer

Imbrium Therapeutics L.P. announced that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational drug etoposide toniribate, a novel topoisomerase II inhibitor, for the treatment of relapsed refractory biliary tract cancer.

February 22, 2019

·

7 min read